Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Brain Activation Studies Neuroanatomical studies using c-Fos immunoreactivity (a marker of neuronal activation) mapped PT-141s central effects: Activation concentrated in hypothalamic nuclei including mPOA, paraventricular nucleus, and arcuate nucleus Limbic system activation in regions processing reward and motivation Dose-dependent activation patterns correlating with behavioral responses Selective activation in regions known to control sexual function across species Clinical Translation Gap: Despite robust preclinical evidence and successful Phase 3 trials in women, PT-141 currently has FDA approval only for premenopausal women with HSDD
Collaborators GBDRF
GLP-3 is an informal nickname that spread in 2026 after outlets including Fox News, Scientific American, and MedicalXpress used it to describe retatrutide in headlines about its Phase 3 trial results
Implementation of the L-carnitine biosynthesis pathway was guided by the recently developed L-carnitine biosensor, which allowed the identification of the enzymes and their assembly into an optimized biosynthetic pathway in the form of an enzyme cascade
US$ 22.88
US$ 20.95
US$ 23.57
US$ 28.56
US$ 28.60
US$ 24.27
US$ 27.02
